Equities

Shanghai Fudan Forward S&T Co Ltd

600624:SHH

Shanghai Fudan Forward S&T Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)3.22
  • Today's Change0.02 / 0.63%
  • Shares traded22.33m
  • 1 Year change-45.97%
  • Beta1.1749
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shanghai Fudan Forward S&T Co Ltd had revenues fall -13.86% from 789.01m to 679.68m, though the company grew net income from a loss of 6.20m to a gain of 5.96m.
Gross margin38.30%
Net profit margin1.14%
Operating margin-0.07%
Return on assets0.43%
Return on equity0.90%
Return on investment0.74%
More ▼

Cash flow in CNYView more

In 2023, Shanghai Fudan Forward S&T Co Ltd did not generate a significant amount of cash. However, Cash Flow from Investing totalled 59.42m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 7.03m in cash from operations while cash used for financing totalled 69.86m.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.15
Tangible book value per share1.04
More ▼

Balance sheet in CNYView more

Shanghai Fudan Forward S&T Co Ltd has a Debt to Total Capital ratio of 39.50%, a higher figure than the previous year's 4.06%.
Current ratio1.44
Quick ratio0.4148
Total debt/total equity0.6867
Total debt/total capital0.395
More ▼

Growth rates in CNY

Year on year, growth in earnings per share excluding extraordinary items increased 202.21%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)0.06%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-32.46
EPS (TTM) vs
TTM 1 year ago
209.91
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.